CD47 blockade enhances immunoradiotherapy response in head and neck squamous cell carcinoma
Abdula Monther, Riyam Al Msari, Robert Saddawi‐Konefka…·Joseph A. Califano
This study shows CD47 blockade combined with anti-PD1 and radiotherapy improves tumor response in HNSCC by enhancing antigen presentation and immune cell infiltration.